These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19927146)

  • 1. Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: results from large scale efficacy trials.
    Horton ES
    Obesity (Silver Spring); 2009 Dec; 17 Suppl 3():S43-8. PubMed ID: 19927146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals.
    Gaesser GA; Angadi SS; Sawyer BJ
    Phys Sportsmed; 2011 May; 39(2):87-97. PubMed ID: 21673488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of type 2 diabetes: what is the evidence?
    Chiasson JL; Brindisi MC; Rabasa-Lhoret R
    Minerva Endocrinol; 2005 Sep; 30(3):179-91. PubMed ID: 16208307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic implications of diabetes in cardiovascular disease.
    Cherian B; Meka N; Katragadda S; Arora R
    Am J Ther; 2009; 16(6):e51-9. PubMed ID: 19940606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition and prevention of type 2 diabetes.
    Costacou T; Mayer-Davis EJ
    Annu Rev Nutr; 2003; 23():147-70. PubMed ID: 12626686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
    Schäfer S; Kantartzis K; Machann J; Venter C; Niess A; Schick F; Machicao F; Häring HU; Fritsche A; Stefan N
    Eur J Clin Invest; 2007 Jul; 37(7):535-43. PubMed ID: 17576204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle intervention, glucose tolerance, and risk of developing type 2 diabetes mellitus.
    Mensink M
    Metab Syndr Relat Disord; 2005; 3(1):26-34. PubMed ID: 18370707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and exercise in the prevention of diabetes.
    Ryan DH;
    Int J Clin Pract Suppl; 2003 Mar; (134):28-35. PubMed ID: 12793595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of obesity and lifestyle interventions in the prevention and management of type 2 diabetes.
    Davis N; Forges B; Wylie-Rosett J
    Minerva Med; 2009 Jun; 100(3):221-8. PubMed ID: 19571786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update.
    Selwyn AP
    Am J Cardiol; 2007 Dec; 100(12A):33P-37P. PubMed ID: 18154745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The results of Look AHEAD do not row against the implementation of lifestyle changes in patients with type 2 diabetes.
    Annuzzi G; Rivellese AA; Bozzetto L; Riccardi G
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):4-9. PubMed ID: 24388434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome.
    Balducci S; Zanuso S; Massarini M; Corigliano G; Nicolucci A; Missori S; Cavallo S; Cardelli P; Alessi E; Pugliese G; Fallucca F;
    Nutr Metab Cardiovasc Dis; 2008 Nov; 18(9):585-95. PubMed ID: 18061415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle modification in management of diabetes mellitus.
    Sahay BK; Sahay RK
    J Indian Med Assoc; 2002 Mar; 100(3):178-80. PubMed ID: 12408279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in cardiovascular disease risk factors: 6-month results from Project Active.
    Dunn AL; Marcus BH; Kampert JB; Garcia ME; Kohl HW; Blair SN
    Prev Med; 1997; 26(6):883-92. PubMed ID: 9388801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.
    Singh RB; Rastogi SS; Rao PV; Das S; Madhu SV; Das AK; Sahay BK; Fuse SM; Beegom R; Sainani GS; Shah NA
    J Cardiovasc Risk; 1997 Jun; 4(3):201-8. PubMed ID: 9475675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of type 2 diabetes mellitus: is it feasible?
    Palermo A; Maggi D; Maurizi AR; Pozzilli P; Buzzetti R
    Diabetes Metab Res Rev; 2014 Mar; 30 Suppl 1():4-12. PubMed ID: 24353270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.